The Value of PET/CT-Based Radiomics in Predicting Adrenal Metastases in Patients with Cancer

PET/CT放射组学在预测癌症患者肾上腺转移中的价值

阅读:2

Abstract

Objectives: Differentiation of adrenal incidentalomas (AIs) remains a challenge in the oncological setting. The aim of the study was to explore the diagnostic efficacy of [18F]Fluorodeoxyglucose (FDG) positron emission tomography combined with computed tomography (PET/CT)-based radiomics in identifying adrenal metastases and to compare it with that of conventional PET/CT parameters. Materials: Retrospective analysis was performed on 195 AIs for model construction, nomogram drawing, and internal validation. An additional 30 AIs were collected for external validation of the radiomics model and nomogram. Logistic regression analysis was employed to build models based on clinical and PET/CT routine parameters. The open-source software Python (version 3.7.11) was utilized to process the regions of interest (ROI) delineated by ITK-SNAP, extracting radiomic features. Least absolute shrinkage and selection operator (LASSO) regression analysis was applied for feature selection. Based on the selected features, the optimal model was chosen from ten machine learning algorithms, and the nomogram was constructed. Results: The area under the curve (AUC), sensitivity, specificity, and accuracy of conventional parameters of PET/CT were 0.919, 0.849, 0.892, and 0.844, respectively. XGBoost demonstrated superior diagnostic efficiency among the radiomics models, outperforming those constructed using independent predictors. The AUC, accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of XGBoost's internal and external validation were 0.945, 0.932, 0.930, 0.960, 0.970, 0.890 and 0.910, 0.900, 0.860, 1, 1, 0.750. The accuracy, sensitivity, specificity, PPV, and NPV of the nomogram in external validation were 0.870, 0.952, 0.667, 0.870, and 0.857. Conclusions: The radiomics model and conventional PET/CT parameters both showed high diagnostic performance (AUC p > 0.05) in discriminating adrenal metastases from benign lesions, offering a practical, non-invasive approach for clinical assessment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。